Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates.
Journal
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
ISSN: 1473-5733
Titre abrégé: Blood Coagul Fibrinolysis
Pays: England
ID NLM: 9102551
Informations de publication
Date de publication:
01 Jul 2024
01 Jul 2024
Historique:
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
8
7
2024
Statut:
ppublish
Résumé
We aimed to evaluate the effect of hyperbilirubinemia and phototherapy on total apoptotic, platelet-derived, endothelial-derived, and tissue factor (TF)-positive apoptotic microparticle (MP) levels in neonates with nonhemolytic pathologic hyperbilirubinemia. Thirty-three term neonates with nonhemolytic pathologic hyperbilirubinemia and 25 healthy term neonates were included. MP levels were analyzed by flow cytometry using peripheral blood samples only once for the neonates in the control group and twice for the neonates in the study group (before and after phototherapy). Annexin V-positive MPs were defined as apoptotic MPs. Platelet-derived MPs were defined as those containing CD31. MPs containing CD144 were defined as endothelial-derived MPs, and MPs expressing TF were identified as those containing CD142. The rates of total apoptotic and endothelial-derived apoptotic MPs were significantly higher in the study group than the control group before phototherapy (P = 0.012 and P = 0.003, respectively) and after phototherapy (P = 0.046 and P = 0.001, respectively). Total apoptotic, platelet-derived, endothelial-derived, and TF-positive apoptotic MPs did not show any significant differences before and after phototherapy in the study group (P = 0.908, P = 0.823, P = 0.748, and P = 0.437, respectively). Our study demonstrated that total apoptotic and endothelial-derived apoptotic MPs are increased in cases of nonhemolytic pathologic hyperbilirubinemia. We showed that phototherapy does not have a significant effect on apoptotic MP levels. Further studies are needed to evaluate the risk of elevated apoptotic MPs on the development of thromboembolism in neonates with nonhemolytic pathologic hyperbilirubinemia.
Identifiants
pubmed: 38973516
doi: 10.1097/MBC.0000000000001297
pii: 00001721-202407000-00002
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
227-231Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Curtis AM, Edelberg J, Jonas R, Rogers WT, Moore JS, Syed W, et al. Endothelial microparticles: sophisticated vesicles modulating vascular function. Vasc Med 2013; 18:204–214.
Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21:157–171.
Lacroix R, Dubois C, Leroyer AS, Sabatier F, Dignat-George F. Revisited role of microparticles arterial and venous thrombosis. J Thromb Haemost 2013; 11: (Suppl 1): 24–35.
Hron G, Kollars M, Weber H, Sagaster V, Quehenberger P, Eichinger S, et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007; 97:119–123.
Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5:520–527.
Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335:143–151.
Mooberry MJ, Bradford R, Hobl EL, Lin FC, Jilma B, Key NS. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia. J Thromb Haemost 2016; 14:1031–1042.
Woei-A-Jin FJ, van der Starre WE, Tesselaar ME, Garcia Rodriguez P, van Nieuwkoop C, Bertina RM, et al. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections. Thromb Res 2014; 133:799–803.
Johnson BL 3rd, Midura EF, Prakash PS, Rice TC, Kunz N, Kalies K, et al. Neutrophil derived microparticles increase mortality and the counter-inflammatory response in a murine model of sepsis. Biochim Biophys Acta Mol Basis Dis 2017; 1863:2554–2563.
Matsumoto H, Yamakawa K, Ogura H, Koh T, Matsumoto N, Shimazu T. Clinical significance of tissue factor and CD13 double-positive microparticles in sirs patients with trauma and severe sepsis. Shock 2017; 47:409–415.
Caspers M, Schäfer N, Fröhlich M, Bouillon B, Mutschler M, Bauerfeind U, et al. Microparticles profiling in trauma patients: high level of microparticles induce activation of platelets in vitro. Eur J Trauma Emerg Surg 2020; 46:43–51.
Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, et al. Developmental hemostasis: a lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67:2–13.
Kenet G, Cohen O, Bajorat T, Nowak-Göttl U. Insights into neonatal thrombosis. Thromb Res 2019; 181: (Suppl 1): S33–S36.
Rizzi M, Goldenberg N, Bonduel M, Revel-Vilk S, Amankwah E, Albisetti M. Catheter-related arterial thrombosis in neonates and children: a systematic review. Thromb Haemost 2018; 118:1058–1066.
Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. Am Fam Physician 2014; 89:873–878.
Pace EJ, Brown CM, DeGeorge KC. Neonatal hyperbilirubinemia: an evidence-based approach. J Fam Pract 2019; 68:E4–E11.
Brito MA, Silva RF, Brites D. Bilirubin induces loss of membrane lipids and exposure of phosphatidylserine in human erythrocytes. Cell Biol Toxicol 2002; 18:181–192.
Özkan H, Ören H, Tatli M, Ateş H, Kumral A, Duman N. Erythroid apoptosis in idiopathic neonatal jaundice. Pediatrics 2008; 121:e1348–e1351.
Rawat V, Bortolussi G, Gazzin S, Tiribelli C, Muro AF. Bilirubin-induced oxidative stress leads to DNA damage in the cerebellum of hyperbilirubinemic neonatal mice and activates DNA double-strand break repair pathways in human cells. Oxid Med Cell Longev 2018; 2018:1801243.
Hansen TWR, Maisels MJ, Ebbesen F, Vreman HJ, Stevenson DK, Wong RJ, et al. Sixty years of phototherapy for neonatal jaundice—from serendipitous observation to standardized treatment and rescue for millions. J Perinatol 2020; 40:180–193.
Christensen T, Kinn G, Granli T, Amundsen I. Cells, bilirubin and light: formation of bilirubin photoproducts and cellular damage at defined wavelengths. Acta Paediatr 1994; 83:7–12.
Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770–776.
Tyson JE, Pedroza C, Langer J, Green C, Morris B, Stevenson D, et al. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol 2012; 32:677–684.
El-Abdin MYZ, El-Salam MA, Ibrhm MY, Koraa SSM, Mahmoud E. Phototherapy and DNA changes in full term neonates with hyperbilirubinemia. Egypt J Med Hum Genet 2012; 13:29–35.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010; 77:502–514.
Strasser EF, Happ S, Weiss DR, Pfeiffer A, Zimmermann R, Eckstein R. Microparticle detection in platelet products by three different methods. Transfusion 2013; 53:156–166.
Korbal P, Słomka A, Sadowska-Krawczenko I, Żekanowska E. Evaluation of tissue factor bearing microparticles in the cord blood of preterm and term newborns. Thromb Res 2017; 153:95–96.
Schweintzger S, Schlagenhauf A, Leschnik B, Rinner B, Bernhard H, Novak M, et al. Microparticles in newborn cord blood: slight elevation after normal delivery. Thromb Res 2011; 128:62–67.
Vítková V, Pánek M, Janec P, Šibíková M, Vobruba V, Haluzík M, et al. Endothelial microvesicles and soluble markers of endothelial injury in critically ill newborns. Mediators Inflamm 2018; 2018:1975056.
Awad HA, Tantawy AA, El-Farrash RA, Ismail EA, Youssif NM. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility. Blood Transfus 2014; 12:250–259.
Zhu XJ, Wei JK, Zhang CM. Evaluation of endothelial microparticles as a prognostic marker in hemolytic disease of the newborn in China. J Int Med Res 2019; 47:5732–5739.
Soto Conti CP. Bilirubin: the toxic mechanisms of an antioxidant molecule. Arch Argent Pediatr 2021; 119:e18–e25.
Yahia S, Shabaan AE, Gouida M, El-Ghanam D, Eldegla H, El-Bakary A, et al. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full-term infants. Eur J Pediatr 2015; 174:459–464.
Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK, Rabie WA, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J Perinatol 2016; 36:132–136.